Arkolith/Insider Trading/TARA/Form 4

Shefferman Jesse

CEO and President, DirectorProtara Therapeutics, Inc. (TARA) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$882K
Net Open-Market Flow
-$882K
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Gift(G)7K—$0701K
Jun 30, 2026Gift(G)14K—$0708K
Jun 30, 2026Gift(G)4K—$0697K
Jun 30, 2026Gift(G)5K—$0692K
Jun 29, 2026Sell(S)216K$4.09$882K722K
Jun 29, 2026Option exercise(M)216K$1.91$412K938K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)216K—$0141K

Transaction Codes

G
Gift
S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-074238) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Protara Therapeutics, Inc.

Build

Ask your agent about TARA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001213900-26-074238"
Ask your agent
Use Arkolith to summarize insider buying and selling at Protara Therapeutics, Inc.
over the last 90 days and cite the filings.